The IPO Buzz: Generate Biomedicines Prices IPO at $16 Mid-Point & Stock Falls in NASDAQ Debut

AI-driven Generate Biomedicines  (GENB) priced its IPO at $16.00 – the mid-point of its range – and sold 25 million shares – the number in the prospectus – to raise $400 million on Thursday night, Feb. 26, 2026. Generate Biomedicines (GENB) shares slid $1.00 to start trading at $15.00 on NASDAQ shortly before 1 p.m. EST on Friday, Feb. 27, 2026. The biotech's NASDAQ debut came amid ..

Read more February 27, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Generate Biomedicines GENB Goldman Sachs/Morgan Stanley/Piper Sandler/Guggenheim Securities/Cantor 25.0 16.00 16.00 $ 400.0 mil 2/27/2026 Priced S/O S/O
Illumination Acquisition Corp. I ILLUU BTIG 20.0 10.00 10.00 $ 200.0 mil 2/27/2026 Priced S/O S/O
Iron Dome Acquisition I Corp. IDACU D. Boral Capital (ex-EF Hutton)/ARC Group Securities 20.0 10.00 10.00 $ 200.0 mil 2/27/2026 Friday S/O S/O
Read more

Last 100 IPOs - February 26, 2026

Number of IPOs priced : 100
Number Up: 53
Number Down: 41
Number Unchanged: 6
Percentage Change From Issue Price: -3.48%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - February 26, 2026

Number of IPOs priced (Excluding 47 units) : 29
Number Up: 15
Number Down: 10
Number Unchanged: 4
Total Return From Issue Price: 5.50%
The Nasdaq Composite Index YTD % Change 35.22%